Log In
Print
BCIQ
Print
Print this Print this
 

Adderall

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionMixed salts of a single-entity amphetamine
Molecular Target Unknown
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat attention deficit hyperactivity disorder (ADHD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today